Literature DB >> 15993408

Establishment of two cell lines derived from conjunctival melanomas.

Gordon Nareyeck, Henrike Wuestemeyer, Daniela von der Haar, Gerasimos Anastassiou.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15993408     DOI： 10.1016/j.exer.2005.04.018

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN： 0014-4835            Impact factor:   3.467


× No keyword cloud information.
  13 in total

1.  Chemosensitivity of conjunctival melanoma cell lines to target-specific chemotherapeutic agents.

Authors:  Henrike Westekemper; Michael Freistuehler; Norbert Bornfeld; Klaus-Peter Steuhl; Max Scheulen; Ralf A Hilger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-07-11       Impact factor: 3.117

2.  A new cell line from a recurrent conjunctival melanoma.

Authors:  Sander Keijser; Willem Maat; Guy S Missotten; Rob J W de Keizer
Journal:  Br J Ophthalmol       Date:  2007-11       Impact factor: 4.638

3.  Expression of Multidrug Resistance Transporter ABCB5 in a Murine Model of Human Conjunctival Melanoma.

Authors:  Nadine E de Waard; Paraskevi E Kolovou; Sean P McGuire; Jinfeng Cao; Natasha Y Frank; Markus H Frank; Martine J Jager; Bruce R Ksander
Journal:  Ocul Oncol Pathol       Date:  2015-04

4.  IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma.

Authors:  Dawei Song; Sonia Cismas; Caitrin Crudden; Eric Trocme; Claire Worrall; Naida Suleymanova; Tingting Lin; Huiyuan Zheng; Stefan Seregard; Ada Girnita; Leonard Girnita
Journal:  Oncogene       Date:  2021-11-17       Impact factor: 9.867

5.  Photosubstitution in a trisheteroleptic ruthenium complex inhibits conjunctival melanoma growth in a zebrafish orthotopic xenograft model.

Authors:  Quanchi Chen; Jordi-Amat Cuello-Garibo; Ludovic Bretin; Liyan Zhang; Vadde Ramu; Yasmin Aydar; Yevhen Batsiun; Sharon Bronkhorst; Yurii Husiev; Nataliia Beztsinna; Lanpeng Chen; Xue-Quan Zhou; Claudia Schmidt; Ingo Ott; Martine J Jager; Albert M Brouwer; B Ewa Snaar-Jagalska; Sylvestre Bonnet
Journal:  Chem Sci       Date:  2022-05-16       Impact factor: 9.969

6.  Targeting of the MAPK and AKT pathways in conjunctival melanoma shows potential synergy.

Authors:  Martine J Jager; Robert M Verdijk; Jinfeng Cao; Renier C Heijkants; Aart G Jochemsen; Mehmet Dogrusöz; Mark J de Lange; Pieter A van der Velden; Sjoerd H van der Burg
Journal:  Oncotarget       Date:  2016-07-22

7.  Overexpression of EZH2 in conjunctival melanoma offers a new therapeutic target.

Authors:  Jinfeng Cao; Kelly Cs Pontes; Renier C Heijkants; Niels J Brouwer; Arwin Groenewoud; Ekaterina S Jordanova; Marina Marinkovic; Sjoerd van Duinen; Amina Fas Teunisse; Robert M Verdijk; Ewa Snaar-Jagalska; Aart G Jochemsen; Martine J Jager
Journal:  J Pathol       Date:  2018-06-23       Impact factor: 7.996

8.  PD-L1/PD-1 expression and tumor-infiltrating lymphocytes in conjunctival melanoma.

Authors:  Jinfeng Cao; Niels J Brouwer; Kate E Richards; Marina Marinkovic; Sjoerd van Duinen; Daan Hurkmans; Els M E Verdegaal; Ekaterina S Jordanova; Martine J Jager
Journal:  Oncotarget       Date:  2017-05-20

9.  Image Analysis of 3D Conjunctival Melanoma Cell Cultures Following Electrochemotherapy.

Authors:  Miltiadis Fiorentzis; Periklis Katopodis; Helen Kalirai; Berthold Seitz; Arne Viestenz; Sarah E Coupland
Journal:  Biomedicines       Date:  2020-06-13

10.  TLD1433 Photosensitizer Inhibits Conjunctival Melanoma Cells in Zebrafish Ectopic and Orthotopic Tumour Models.

Authors:  Quanchi Chen; Vadde Ramu; Yasmin Aydar; Arwin Groenewoud; Xue-Quan Zhou; Martine J Jager; Houston Cole; Colin G Cameron; Sherri A McFarland; Sylvestre Bonnet; B Ewa Snaar-Jagalska
Journal:  Cancers (Basel)       Date:  2020-03-04       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.